October is Liver Awareness Month, and the Pulmonary Hypertension Association together with the American Liver Foundation are sharing with the general public information on a long-established relationship between hepatic disease and pulmonary hypertension. The new initiative aims to spread awareness, enhance patient education and knowledge,…
Quebec residents living with pulmonary arterial hypertension (PAH) now have access to a breakthrough, publicly funded drug called Opsumit (macitentan), a once-a-day oral formulation of a dual endothelia receptor antagonist (ERA). On October 1, the Institut national d’excellence en santé et services sociaux (INESSS) recommended that the Régie de l’assurance maladie…
Chloe Temtchine, a singer who suffers from pulmonary hypertension and decided to advocate for the disease using her career, is performing at the New York City O2 breathe Gala on November 6, 2014. Temtchine is going to sing her theme Be Brave, which was launched last…
One of the fundamental steps to gaining more support for much-needed research and development is to first raise awareness among the general public and potential investors. One of the most effective means of rallying support is to publish inspiring stories about people living with a…
The Maryland-based Pulmonary Hypertension Association (PHA), the most prominent organization in the country committed to the prevention, research, education, and advocacy of pulmonary hypertension (PH), has just announced that it has accredited the first 6 Pulmonary Hypertension Care Centers (PHCC) in the US, as part of its…
The Pulmonary Hypertension Association has announced that it is launching a new PHA Patient Telephone Support Group to help patients who suffer from pulmonary hypertension (PH). The support group will offer support to patients, especially those who were recently diagnosed, and will consist of monthly telephone dialogues for…
The Pulmonary Hypertension Association (PHA) is hosting their annual educational event “PHA On The Road,” a free educational forum to help both pulmonary hypertension (PH) patients and their families and caregivers fight the rare lung disease, which affects blood pressure in the lungs, and with no…
Despite the widely held observation that inflammation leads to deadly scarring in idiopathic pulmonary fibrosis, according to a new study conducted at the National Jewish Health, some inflammation may help in the healing and repair process of the lung. Assistant professor of cell biology Elizabeth Redente, PhD, and her research team discovered…
Pulmonary hypertension is a life-threatening, progressive disease that, to this day, is still incurable. Recently, a team of researchers turned to nature for answers, experimenting with extracting a protective enzyme from plant leaves that may hold the key to making a novel treatment work. Lead author and assistant…
The Maryland chapter of the Pulmonary Hypertension Association (PHA) recently announced that it is hosting a presentation on Emergency Preparedness for Pulmonary Hypertension Patients, via their Facebook page, which is taking place on Tuesday, September 23rd at 10 pm. The event is designed to help educated patients on…
Pulmonary hypertension occurs when there is an abnormal buildup of blood pressure pumped from the heart to the pulmonary vasculature, eventually causing the vessels in the lungs to constrict and lead to a reduction in blood oxygenation. At present, this deadly disease remains incurable, with a 68 percent chance…
Biopharm company, Insmed Incorporated, has announced that they will present their novel inhalation technologies for the treatment of orphan pulmonary diseases such as pulmonary arterial hypertension at the European Respiratory Society’s (ERS) International Congress 2014. Held between September 6th and 10th at the Internationales Congress Center München, in…
Get regular updates to your inbox.